COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,386 Articles (22,816 medRxiv, 8,570 bioRxiv)

Most recent first Previous |  Page 1253: Articles 12521-12530  | Next

Widening Disparities in Online Information Access during the COVID-19 Pandemic
Suh, J., Horvitz, E., White, R. W., Althoff, T.
10.1101/2021.09.14.21263545 — Posted: 2021-09-17
Dysregulated immune responses in COVID-19 patients correlating with disease severity and invasive oxygen requirements
Garcia-Gonzalez, P., Tempio, F., Fuentes, C., Merino, C., Vargas, L., Simon, V., Ramirez, M., Rojas, V., Tobar, E., Landskron, G., Araya, J. P., Navarrete, M., Bastias, C., Tordecilla, R., Varas, M., Maturana, P., Marcoleta, A., Allende, M., Naves, R., Hermoso, M., Salazar-Onfray, F., Lopez, M., Bono, M. R., Osorio, F.
10.1101/2021.09.14.21263541 — Posted: 2021-09-17
Geographic and Phylodynamic Distribution of SARS-CoV-2 from Environmental Origin
Oladipo, E. K., Irewolede, B. A., Oyewole, P. M., Dairo, E. O., Ayeni, A. E., Adetunji, C. O., Oloke, J. K.
10.1101/2021.09.13.21263432 — Posted: 2021-09-16
Neutralizing antibody-independent immunity to SARS-CoV-2 in hamsters and hACE-2 transgenic mice immunized with a RBD/Nucleocapsid fusion protein
Castro, J., Fumagalli, M., Hojo-Souza, N., Azevedo, P., Salazar, N., Rattis, B., Ramos, S., Faustino, L., Almeida, G., Oliveira, L., Marcal, T., Augusto, M., Magalhaes, R. D. M., Cassaro, B., Burle, G., Doro, D., Kalil, J., Durigon, E. L., Salazar, A., Caballero, O., Machado, A., da Silva, J., da Fonseca, F., Fernandes, A. P., Teixeira, S., Gazzinelli, R.
10.1101/2021.09.16.460663 — Posted: 2021-09-16
Signatures of adaptive evolution during human to mink SARS CoV2 cross species transmission inform estimates of the COVID19 pandemic timing
Tai, J.-H., Chaw, S.-M., Sun, H.-Y., Tseng, Y.-C., Li, G., Chang, S.-Y., Yeh, S.-H., Chen, P.-J., Wang, H.-Y.
10.1101/2021.09.15.459215 — Posted: 2021-09-16
Humoral immune responses against seasonal coronaviruses predict efficiency of SARS-CoV-2 spike targeting, FcγR activation, and corresponding COVID-19 disease severity
Garrido, J. J., Medina, M., Bravo, F., McGee, S., Fuentes, F., Calvo, M., Bowman, J. W., Bahl, C. D., Barria, M. I., Brachman, R. A., Alvarez, R. A.
10.1101/2021.09.14.460338 — Posted: 2021-09-16
Dual domain recognition determines SARS-CoV-2 PLpro selectivity for human ISG15 and K48-linked di-ubiquitin
Osipiuk, J., Wydorski, P. M., Lanham, B. T., Tesar, C., Endres, M., Engle, E., Jedrzejczak, R., Mullapudi, V., Michalska, K., Fidelis, K., Fushman, D., Joachimiak, A., Joachimiak, L. A.
10.1101/2021.09.15.460543 — Posted: 2021-09-16
Persistent oxidative stress and inflammasome activation in CD14highCD16- monocytes from COVID-19 patients
Lucena Lage, S., Pinheiro Amaral, E., Hilligan, k. L., Laidlaw, E., Rupert, A., Namasivayan, S., Rocco, J., Galindo, F., Kellogg, A., Kumar, P., Poon, R., Wortmann, G. W., Shannon, J. P., Hickman, H. D., Lisco, A., Manion, M., Sher, A., Sereti, I.
10.1101/2021.09.13.21263292 — Posted: 2021-09-16
Reduced levels of convalescent neutralizing antibodies against SARS-CoV-2 B.1+L249S+E484K lineage
Alvarez Diaz, D. A., Laiton Donato, K., Torres Garcia, O. A., Ruiz Moreno, H. A., Franco Munoz, C. E., Beltran, M. A., Mercado Reyes, M., Rueda, M. G., Munoz Ramirez, A. L.
10.1101/2021.09.13.21263430 — Posted: 2021-09-16
Using Artificial Intelligence-based models to predict the risk of Mucormycosis among COVID-19 Survivors: An Experience from India
Syed-Abdul, S., Babu, A. S., Bellamkonda, R. S., Itumalla, R., Acharyulu, G., Krishnamurthy, S., Ramana, Y. V. S., Mogilicharla, N., Malwade, S., Li, Y.-C.
10.1101/2021.09.13.21263511 — Posted: 2021-09-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).